July 2026
M	T	W	T	F	S	S
	1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Timothy Glidewell on CosMx – A Promise for Severe Aplastic Anemia

Timothy Glidewell/LinkedIn

Dec 22, 2025, 16:18

Timothy Glidewell on CosMx – A Promise for Severe Aplastic Anemia

Timothy Glidewell, Spatial Regional Account Manager at Bruker Spatial, reposted from The National Institutes of Health on LinkedIn:

”The latest NCI update on an experimental therapy for severe aplastic anemia is an important signal for anyone thinking about bone marrow failure, immune dysregulation, and why only some patients respond to treatment.

To truly unravel these questions, we need to see how stem/progenitor cells, stromal support cells, and immune effectors are organized and interacting in situ.

That’s where CosMx™ Spatial Molecular Imager can help—enabling single-cell, subcellular, whole-transcriptome views of rare cell populations within the marrow niche.

These insights can support translational teams working to understand mechanisms of response and resistance in severe, immune-mediated diseases.

If you’re in the Bay Area and would like to discuss how these spatial biology platforms could support your research, feel free to reach out!”

Quoting The National Institutes of Health‘s post:

”NEWS: An NIH clinical trial has shown promise for an experimental treatment for people with severe aplastic anemia, a life-threatening disorder with limited treatments.”

Read the full announcement here.

Timothy Glidewell on CosMx - A Promise for Severe Aplastic Anemia